Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows – Operating activities:
Net earnings, including noncontrolling interests	$ 154,367	$ 85,151
Adjustments to reconcile net earnings (loss) to net cash provided (used) by operating activities:
Depreciation	37,883	37,452
Amortization of intangible and other assets	4,391	5,158
Loss on sale of business	12,981	0
Stock-based compensation	17,400	15,878
Foreign currency, asset write downs and other non-cash adjustments	10,935	(8,418)
Change in assets and liabilities:
Accounts receivable, net	(168,540)	(5,350)
Inventories	3,603	(99,240)
Contract assets, net	(13,267)	9,917
Prepaid expenses and other, net	10,945	(105)
Accounts payable	14,376	7,118
Contract liabilities	10,894	10,831
Accrued liabilities	(47,795)	(2,091)
Retirement obligations and other liabilities	4,402	8,412
Net deferred taxes	(3,100)	(14,329)
Net cash flows provided (used) by operating activities	49,475	50,384
Cash flows – Investing activities:
Capital expenditures	(28,289)	(31,893)
Payments for disposition of business	(2,352)	0
Other	551	(941)
Net cash flows provided (used) by investing activities	(30,090)	(32,834)
Cash flows – Financing activities:
Payments on term loan	(30,000)	(20,000)
Proceeds under revolving credit facility	100,000	150,000
Payments under revolving credit facility	(25,000)	(100,000)
Proceeds under other financing arrangements	562	197
Payments under other financing arrangements	(1,460)	(3,458)
Repurchases of common shares	(16,161)	0
Payments related to tax withholding for stock-based compensation	(9,093)	(6,235)
Payments of dividends	(55,259)	(52,471)
Other	(272)	(320)
Net cash flows provided (used) by financing activities	(36,683)	(32,287)
Effect of exchange rate changes on cash and cash equivalents	(13,297)	2,603
Net change in cash and cash equivalents	(30,595)	(12,134)
Cash and cash equivalents at beginning of period	545,678	434,971
Cash and cash equivalents at end of period	$ 515,083	$ 422,837